Recent News
Reflecting on the First Year of My Column, ‘Mutations & Conversations’Armata Announces New Treatment Candidate for P. Aeruginosa Infections in CF Patients
New Agreement in Scotland Grants CF Patients Access to Orkambi and Symkevi
Safety, Early Effectiveness of POL6014 Confirmed in Phase 1 Trial
ICER Seeking Feedback on CF Treatments from Stakeholders
No comments:
Post a Comment